CVS Caremark Corporation R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CVS R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Mar 1987 |
| Maximum | 0.00 | Mar 1987 |
| Average |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these CVS related companies
CVS News
UBS Maintains a 'Buy' on CVS Caremark (CVS); Raising FY12/13 EPS Estimates
Feb 09, 2:36PM Street Insider
Feb 09, 2:36PM Street Insider
I guess $WAG's pain is $CVS's gain. Will be interesting to see how sticky their new biz is if Walgreens ever figures out the $ESRX deal.
about 4 days ago by bradloncar
about 4 days ago by bradloncar
CVS Caremark's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 08, 2:40PM Seeking Alpha
Feb 08, 2:40PM Seeking Alpha
CVS (CVS) Posts 16% Rise in Q4 Profit as Pharmacy Services Segment Outperforms
Feb 08, 8:24AM Street Insider
Feb 08, 8:24AM Street Insider
Listen to $CVS Q4 2011 earnings call (EPS 0.89 vs est 0.89) - live at 08:30 AM, ondemand after - http://stks.co/2Ikd
about 5 days ago by earningscast
about 5 days ago by earningscast
CVS Caremark (CVS) Reports In-Line Q4 EPS; Boosts Q112 EPS, Guides FY12 EPS
Feb 08, 6:47AM Street Insider
Feb 08, 6:47AM Street Insider
Watch list + In Play For Feb 8: http://stks.co/2ISg $DIS $CVS $CTSH $TWX $CNQ $APC $TSO $ANF $$
about 5 days ago by TheArmoTrader
about 5 days ago by TheArmoTrader
$wag vs $cvs--just based on my personal experiences--really prefer cvs
about 5 days ago by eddyhooks
about 5 days ago by eddyhooks
Q4 Preview: CVS (CVS) Quarter Should Be Telegraphed But Investors Will Want Details
Feb 07, 4:36PM Street Insider
Feb 07, 4:36PM Street Insider
CVS Caremark Charitable Trust "Surprises" Non-Profits With $4.3 Million in Funding
Feb 07, 1:25PM PR Newswire
Feb 07, 1:25PM PR Newswire
Is Medco-Express Scripts deal dead? $MHS & $ESRX tanked yesterday but both up a bit pre-market today. Keep eye on them as well as $CVS $WAG.
about 6 days ago by lamonicabuzz
about 6 days ago by lamonicabuzz
63 $SPY Holdings Have A NR7 Day. Number has been low recently worth noting. $CVS $AMD $HOG charts pullbacks in uptrends http://stks.co/2BCC
about 12 days ago by tradewithpete
about 12 days ago by tradewithpete
$CVS agrees to pay $5M to settle Medicare drug false advertising claims
about 25 days ago by MoodTrader
about 25 days ago by MoodTrader
Stocks trading ex-dividend one week from today: http://stks.co/1tnr $APA $BCR $CODI $CVS $HRL $LTC
about 31 days ago by DynamicDividend
about 31 days ago by DynamicDividend
Baby Buffetteer Todd Combs Cruuuuuuushing It So Far | via @ReformedBroker http://stks.co/1sw2 $V $BRK-B $MA $GD $DTV $INTC $CVS
about 32 days ago by STNet
about 32 days ago by STNet
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CVS | 43.18 | 0.18 | 0.42% | 56.20B |
| JPM | 37.61 | -0.25 | -0.66% | 142.91B |
| FITB | 13.35 | -0.17 | -1.29% | 12.27B |
| T | 29.84 | -0.15 | -0.50% | 176.83B |
| KFT | 38.58 | -0.06 | -0.16% | 68.14B |
| EBAY | 33.02 | -0.23 | -0.71% | 42.63B |
| FRP | 4.42 | -0.43 | -8.87% | |
| IO | 8.05 | -0.46 | -5.41% | 1.25B |
| APC | 87.04 | -0.42 | -0.48% | 43.34B |
| HBAN | 5.91 | -0.12 | -2.07% | 5.10B |
